English Policies and Consultations

The RPS England team produces policies and consultation responses in England, and contributes to GB-wide policies and consultations where they are relevant in England.

1. Open Consultations in England

England only

• Currently there are no England Specific consultation

To comment on any of these consultations, email [email protected]

GB consultations relevant to England

• Hub and Spoke dispensing | DHSC
• Consultation on the draft equality guidance for pharmacies I GPhC

To comment on any of these consultations, email [email protected]

2. Policies in development

There are currently no policies in development. 

To help us develop this policy, email [email protected]

3. Policies

• COVID-19vaccinations for pharmacists | (GB)
• Workforce: Improving capacity and culture | (GB)
• Drug deaths and the role of the pharmacy team  | (GB)
• Pharmacist Independent Prescribing | (GB)
• Caring for Long Covid Patients | (GB)
• The role of pharmacy in mental health and wellbeing | (GB)
  
• Women’s Health | (GB)
  
• Using community pharmacists to support people with cancer | (England)
  
• Using pharmacists to help improve care for people with Type II diabetes | (England)
  
• Future of pharmacy in a sustainable NHS | (GB)
  
• Medicines shortages | (GB)

Link to all our policies

4. Recent consultations from 2021/2022

August 2022

• RPS response to consultation on Low Priority Prescribing Guidance Refresh

July 2022

• RPS response to Mental Health and Wellbeing Plan Discussion Paper 

June 2022

• RPS response to consultation of Hub and Spoke Dispensing online survey
• RPS response to consultation on Vitamin D call for evidence
• RPS response to consultation on GPhC Equality Standards Guidance | GPhC

May 2022

• RPS response to consultation on Aquiette (oxybutynin hydrochloride) POM to P

April 2022

• RPS response to 10-Year Cancer Plan: Call for Evidence  | DHSC
• RPS response to UK COVID-19 Inquiry: Have your say  | COVID Enquiry
• RPS response to consultation on Healthcare regulation: deciding when statutory regulation is appropriate | DHSC
• RPS submission to Fuller Stocktake

March 2022

• RPS response to Disability Workforce Reporting consultation | HM Government
• RPS response to proposals for legislative change for Clinical Trials | MHRA
• RPS response to consultation on Self Harm draft guideline - assessment, management and preventing recurrence | NICE
• Amendments to the Poisons Act 1972 Consultation | Home Office
• RPS response to Home Affairs Committee inquiry into illegal drug use in the UK   HM Government

February 2022

• RPS response to consultation on revoking vaccination as a condition of deployment across all health and social care | NHS England
• RPS response to the General Pharmaceutical Council consultation on remote hearings consultation | GPhC
• RPS response to consultation on Call for Signatories – supervised Overdose Prevention Centres | FPHC

January 2022

• RPS response to consultation on vaccination uptake in the general population | NICE
• RPS response to Depression in adults: treatment and management | NICE

December 2021

• RPS response to consultation for original pack dispensing and supply of medicines containing sodium | DHSC
• RPS response to consultation on Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults  | NICE     
• RPS response to Review of temporary provisions in the Human Medicines Regulations 2012 to support influenza and Covid-19 vaccination campaigns | DHSC
• Amending the Road Traffic Act 1988 to allow registered healthcare professionals to complete DVLA medical questionnaires I DVLA     

November 2021

• CORE20PLUS5 approach to reducing health inequalities | NHSE/I
• RPS response to GPhC Consultation on changes to requirements for training as a pharmacist independent prescriber I GPHC

Link to all our consultation responses